Connect your AI

LivaNova LIVN Accounts Receivable

Accounts Receivable at other companies

AbbottABT

$8.21B+12.1%

HaemoneticsHAE

$216.86M+7.0%

MedtronicMDT

$6.64B+2.0%

ITG

Integer HoldingsITGR

$327.78M+18.7%

ResMedRMD

$998.84M+10.0%

Boston ScientificBSX

$3.15B+12.4%

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.32B+62.8%

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's accounts receivable?: LivaNova (LIVN) reported accounts receivable of $229.27M in Q1 2026.
How has LivaNova's accounts receivable changed year-over-year?: LivaNova's accounts receivable increased by 13.5% year-over-year, from $202.08M to $229.27M.
What is the long-term trend for LivaNova's accounts receivable?: Over 5 years (2020 to 2025), LivaNova's accounts receivable has grown at a 3.2% compound annual growth rate (CAGR), from $184.36M to $215.99M.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.